Clinical significance of CD41-positive blasts in association with a monosomal karyotype in patients with myelodysplastic syndrome treated with azacitidine

Br J Haematol. 2020 May;189(4):e144-e147. doi: 10.1111/bjh.16565. Epub 2020 Mar 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antimetabolites, Antineoplastic / pharmacology
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Azacitidine / pharmacology
  • Azacitidine / therapeutic use*
  • Female
  • Humans
  • Karyotype
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / drug therapy*
  • Myelodysplastic Syndromes / immunology*
  • Platelet Membrane Glycoprotein IIb / immunology*
  • Young Adult

Substances

  • Antimetabolites, Antineoplastic
  • Platelet Membrane Glycoprotein IIb
  • Azacitidine